Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Seattle Genetics achieves $30 million milestone payment for EC approval of ADCETRIS®
Seattle Genetics announced that its collaborator, Takeda Pharmaceutical, received approval from the EC to extend the MA for ADCETRIS (brentuximab vedotin) in adults patients with previously untreated CD30+ stage IV classical HL.
February 11, 2019
More...
Email This Page
to a Friend
Print This
Page